The U.S. Food and Drug Administration on Wednesday amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 vaccines to authorize updated boosters to combat omicron ...

Add Yahoo as a preferred source to see more of our stories on Google. A vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at a mass vaccination center on July 1, 2021 in Leipzig, Germany.

Add Yahoo as a preferred source to see more of our stories on Google. In this photo illustration, Pfizer-BioNTech COVID-19 and Moderna COVID-19 vaccines fill their syringes at Borinquen Health Care ...

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days. The move by the Food and Drug ...

WASHINGTON -- The US Food and Drug Administration gave the green light Monday to updated COVID-19 vaccines from Moderna and Pfizer/BioNTech amid rising cases and hospitalizations. Both vaccine ...

The Food and Drug Administration on Tuesday authorized a second dose of the updated COVID boo ster for older adults and people with weakened immune systems. Those 65 and older can get a second dose of ...

WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants 1 – compared to ...

WASHINGTON -- Moderna submitted its application to the U.S. Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older, the ...